Lamivudine is safe and effective in fulminant hepatitis B.
Santantonio
T
T
Mazzola
M
M
Pastore
G
G
D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine